


VANCOUVER, BRITISH COLUMBIA--(Marketwire - Nov. 9, 2009) - Tekmira Pharmaceuticals Corporation (TSX:TKM), a leading developer of RNA interference (RNAi) therapeutics and proprietary delivery technology, announced today that it will hold a conference call and webcast on Thursday November 12, 2009 at 1:30 pm Pacific Time (4:30 pm Eastern Time) to discuss third quarter 2009 operating results and to provide a corporate update.
About the Conference Call
To participate in the conference call, please dial 416-695-6617 or 1-800-355-4959. The call will be available for replay until November 26, 2009 by calling 416-695-5800 or 1-800-408-3053 and entering the code 2875305.
The live or archived webcast can also be accessed through the Company's website at [ www.tekmirapharm.com ].
About Tekmira
Tekmira Pharmaceuticals Corporation is a biopharmaceutical company focused on advancing novel RNAi therapeutics and providing its leading lipid nanoparticle delivery technology to pharmaceutical partners. Further information about Tekmira can be found at [ www.tekmirapharm.com ]. Tekmira is based in Vancouver, B.C.